Regenxbio (RGNX) Interest & Investment Income (2015 - 2026)
Regenxbio (RGNX) reported Interest & Investment Income of $1.22 million for Q2 2026, down 63.8% from $3.38 million a year earlier and down 39.0% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Interest & Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regenxbio's Interest & Investment Income came in at $9.59 million, down 48.6% year-over-year; for FY2025, it came in at $12.25 million, down 34.6% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $18.73 million in FY2024 (+65.5%), $11.32 million in FY2023 (+110.3%), $5.38 million in FY2022 (-21.1%) and $6.83 million in FY2021 (-29.8%).
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q2 2022.
- Year over year, Interest & Investment Income has now declined in each of the last three quarters, with growth averaging 15.9% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q4 2022 (growth of 551.4%); the low point was Q4 2021 (a decline of 97.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2 million (Q1 2026), $2.75 million (Q4 2025) and $3.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | 2.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.25 Mn |
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 3.62 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 9.52 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 799,000.00 |
| Dec 31, 2021 | 311,000.00 |
API Access
Regenxbio Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();